517 related articles for article (PubMed ID: 27240542)
1. Cyanidin 3-O-β-glucopyranoside activates peroxisome proliferator-activated receptor-γ and alleviates cognitive impairment in the APP(swe)/PS1(ΔE9) mouse model.
Song N; Zhang L; Chen W; Zhu H; Deng W; Han Y; Guo J; Qin C
Biochim Biophys Acta; 2016 Sep; 1862(9):1786-800. PubMed ID: 27240542
[TBL] [Abstract][Full Text] [Related]
2. Intranasal 15d-PGJ2 ameliorates brain glucose hypometabolism via PPARγ-dependent activation of PGC-1α/GLUT4 signalling in APP/PS1 transgenic mice.
Li Z; Zhang Y; Zheng Y; Liu W; Zhang X; Li W; Zhang D; Cai Q; Wang S; Meng X; Huang G
Neuropharmacology; 2021 Sep; 196():108685. PubMed ID: 34175325
[TBL] [Abstract][Full Text] [Related]
3. Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Aβ Accumulation.
Li Z; Li H; Zhao C; Lv C; Zhong C; Xin W; Zhang W
CNS Neurol Disord Drug Targets; 2015; 14(3):360-9. PubMed ID: 25714973
[TBL] [Abstract][Full Text] [Related]
4. Effective expression of Drebrin in hippocampus improves cognitive function and alleviates lesions of Alzheimer's disease in APP (swe)/PS1 (ΔE9) mice.
Liu Y; Xu YF; Zhang L; Huang L; Yu P; Zhu H; Deng W; Qin C
CNS Neurosci Ther; 2017 Jul; 23(7):590-604. PubMed ID: 28597477
[TBL] [Abstract][Full Text] [Related]
5. Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-β pathology in a mouse model of Alzheimer's disease.
Li L; Zhang S; Zhang X; Li T; Tang Y; Liu H; Yang W; Le W
Curr Alzheimer Res; 2013 May; 10(4):433-41. PubMed ID: 23305067
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
[TBL] [Abstract][Full Text] [Related]
7. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.
Yuan C; Guo X; Zhou Q; Du F; Jiang W; Zhou X; Liu P; Chi T; Ji X; Gao J; Chen C; Lang H; Xu J; Liu D; Yang Y; Qiu S; Tang X; Chen G; Zou L
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):161-180. PubMed ID: 30389579
[TBL] [Abstract][Full Text] [Related]
8. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
9. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
Chang KL; Wong LR; Pee HN; Yang S; Ho PC
Mol Neurobiol; 2019 Nov; 56(11):7267-7283. PubMed ID: 31016475
[TBL] [Abstract][Full Text] [Related]
10. Alpha-Linolenic Acid from Perilla frutescens var. japonica Oil Protects Aβ-Induced Cognitive Impairment through Regulation of APP Processing and Aβ Degradation.
Lee AY; Lee MH; Lee S; Cho EJ
J Agric Food Chem; 2017 Dec; 65(49):10719-10729. PubMed ID: 29092397
[TBL] [Abstract][Full Text] [Related]
11. Anthocyanin-enriched bilberry and blackcurrant extracts modulate amyloid precursor protein processing and alleviate behavioral abnormalities in the APP/PS1 mouse model of Alzheimer's disease.
Vepsäläinen S; Koivisto H; Pekkarinen E; Mäkinen P; Dobson G; McDougall GJ; Stewart D; Haapasalo A; Karjalainen RO; Tanila H; Hiltunen M
J Nutr Biochem; 2013 Jan; 24(1):360-70. PubMed ID: 22995388
[TBL] [Abstract][Full Text] [Related]
12. Astragaloside IV, a Natural PPARγ Agonist, Reduces Aβ Production in Alzheimer's Disease Through Inhibition of BACE1.
Wang X; Wang Y; Hu JP; Yu S; Li BK; Cui Y; Ren L; Zhang LD
Mol Neurobiol; 2017 May; 54(4):2939-2949. PubMed ID: 27023226
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of cyanidin 3-O-glucoside on beta-amyloid peptide-induced cognitive impairment in rats.
Qin L; Zhang J; Qin M
Neurosci Lett; 2013 Feb; 534():285-8. PubMed ID: 23274703
[TBL] [Abstract][Full Text] [Related]
14. 27-hydroxycholesterol promotes Aβ accumulation via altering Aβ metabolism in mild cognitive impairment patients and APP/PS1 mice.
Zhang X; Xi Y; Yu H; An Y; Wang Y; Tao L; Wang Y; Liu W; Wang T; Xiao R
Brain Pathol; 2019 Jul; 29(4):558-573. PubMed ID: 30582229
[TBL] [Abstract][Full Text] [Related]
15. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
[TBL] [Abstract][Full Text] [Related]
16. Increasing brain glucose uptake by Gypenoside LXXV ameliorates cognitive deficits in a mouse model of diabetic Alzheimer's disease.
Meng X; Zhang Y; Li Z; Ma G; Zhang X; Zhang D; Cao W; Wang S; Cai Q; Cui P; Huang G
Phytother Res; 2023 Feb; 37(2):611-626. PubMed ID: 36325883
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
18. Gallic acid disruption of Aβ
Yu M; Chen X; Liu J; Ma Q; Zhuo Z; Chen H; Zhou L; Yang S; Zheng L; Ning C; Xu J; Gao T; Hou ST
Neurobiol Dis; 2019 Apr; 124():67-80. PubMed ID: 30447302
[TBL] [Abstract][Full Text] [Related]
19. Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer's Disease.
Ali T; Kim T; Rehman SU; Khan MS; Amin FU; Khan M; Ikram M; Kim MO
Mol Neurobiol; 2018 Jul; 55(7):6076-6093. PubMed ID: 29170981
[TBL] [Abstract][Full Text] [Related]
20. Increasing brain glucose metabolism by ligustrazine piperazine ameliorates cognitive deficits through PPARγ-dependent enhancement of mitophagy in APP/PS1 mice.
Li Z; Meng X; Ma G; Liu W; Li W; Cai Q; Wang S; Huang G; Zhang Y
Alzheimers Res Ther; 2022 Oct; 14(1):150. PubMed ID: 36217155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
